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Introduction
Cryopyrin associated periodic syndromes (CAPS) is a
spectrum of autoinflammatory syndromes including
familial cold autoinflammatory syndrome, Muckle Wells
syndrome and CINCA (chronic infantile neurologic
articular syndrome). All phenotypes are associated with
gain of function mutation in NLRP3 encoding cryopyrin, a
protein involved in inflammasome and IL-1b processing.
Objectives
We describe clinical features in a large cohort of
patients and test the hypothesis of a génotype/phéno-
type correlation.
Methods
Members of PRINTO were invited to report their
patients to the Eurofever registry via a web-based ques-
tionnaire. Experts in CAPS validated diagnosis in 136
patients. Mean age of the cohort at inclusion was 26 years.
Results
Mean age at disease onset was 5 years. Skin rash, articular
involvement and fever were the most prevalent features,
respectively in 132, 117 and 108 patients. 6 patients suf-
fered from severe articular involvement defined as flexion
contractures, patella overgrowth or bone complications.
Neurological involvement was noticed in 55 patients and
characterized by morning headaches (n=39), aseptic
meningitis (n=23), papilledema (n=29), Severe neurologi-
cal involvement (hydrocephalus, mental retardation, sei-
zures) was reported in 16 patients. Ophthalmological
involvement was observed in 97 patients suffering from
conjunctivitis (n=87), uveitis (n=7), or papilledema. 56
patients presented neurosensorial hearing loss. 78 had a
chronic course, while 58 experienced only acute episodes.
76 cases were familial, 54 sporadic. NLRP3 sequencing
had been performed in all patients; heterozygous germline
mutation was reported in 133 patients. 7 mutations were
recurrent and found in 106 patients: R260W (n= 36),
T348M (n= 20), A439V (n= 14), V198M (n= 13), E311K
(n= 9), Q703K (n= 9), D303N (n= 5), 27 patients carried a
non recurrent mutation; Statistically significant associa-
tions between genotype and phenotype were found:
patients with non recurrent mutations had the most severe
phenotype (youngest age of onset, more frequent neurolo-
gical involvement, including severe ones and severe
arthropathies). Patients carrying R260W mutation were
associated with acute pattern, cold triggering and onset
> 6 months. T348M group was associated with onset < 6
months, a chronic course and frequent hearing loss.
V198M, E311K and A439V were less frequently associated
with neurological involvement.
Conclusion
This retrospective large survey of CAPS patients allowed
to better define genotype-phenotype correlation. Patients
with non-recurrent NLRP3 mutations were identified at
risk of severe disease-related complications. Early effec-
tive treatment with anti-IL1b drugs and close monitoring
should be recommended in these patients.
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